所有图片(1)

文件

COO原产地证书/COA分析证书

568501-U

Discovery^® HS C18 (5 µm) HPLC Columns

Name: Discovery<SUP>&#174;</SUP> HS C18 (5 µm) HPLC Columns
Brand: SUPELCO

L × I.D. 10 cm × 2.1 mm, HPLC Column

登录查看公司和协议定价

所有图片(1)

About This Item

分類程式碼代碼:

41115700

eCl@ss:

32110501

NACRES:

SB.52

推荐产品

Slide 1 of 10

1 of 10

Supelco

568523-U

Discovery^® HS C18 高效液相色谱柱

Supelco

569224-U

Discovery^® C18 高效液相色谱柱

Supelco

504955

Discovery^® C18 高效液相色谱柱

Supelco

504971

Discovery^® C18 高效液相色谱柱

Supelco

581301-U

Ascentis ^® C18 HPLC 色谱柱

Supelco

568533-U

Discovery^® HS C18 高效液相色谱柱

Supelco

569252-U

Discovery^® HS C18 高效液相色谱柱

Supelco

505161

Discovery^® C18 Supelguard 保护柱

Supelco

1.50179

LiChroCART^® 250-10

Supelco

50495521

Discovery^® C18 高效液相色谱柱

product name

Discovery^® HS C18 高效液相色谱柱, 5 μm particle size, L × I.D. 10 cm × 2.1 mm

材料

stainless steel column

agency

suitable for USP L1

產品線

Discovery^®

特點

endcapped

製造商／商標名

Discovery^®

包裝

1 ea of

標籤範圍

20% Carbon loading

參數

≤70 °C temp. range
400 bar pressure (5801 psi)

技術

HPLC: suitable
LC/MS: suitable

長度 × 內徑

10 cm × 2.1 mm

表面積

300 m²/g

表面覆盖率

3.2 μmol/m²

雜質

<10 ppm metals

基質

silica gel, high purity, spherical particle platform
fully porous particle

基質活性組

C18 (octadecyl) phase

粒徑

5 μm

孔徑

120 Å

工作pH值範圍

2-8

應用

food and beverages

分離技術

reversed phase

正在寻找类似产品? 访问产品对比指南

特點和優勢

稳定性好、低流失，适用于 LC-MS 分析
提供有适用于分析型到制备型的各种规格
稳定性好，以确保柱与柱和批与批之间之间优良的重现性
更强的疏水性能够更好地分离难分析化合物

法律資訊

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Simultaneous LC-MS-MS Determination of Lopinavir and Rifabutin in Human Plasma.

Swati Jaiswal et al.

Journal of chromatographic science, 55(6), 617-624 (2017-03-24)

Tuberculosis (TB) with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome represents the most common infectious diseases worldwide. Anti-TB drugs are used concurrently with antiretroviral drug for treatment of TB-HIV co-morbidities. Due to lower risk of interaction with protease inhibitors, rifabutin is

Comparison of chaotropic salt and ionic liquid as mobile phase additives in reversed-phase high-performance liquid chromatography of biogenic amines.

Jolanta Flieger et al.

Journal of separation science, 34(7), 733-739 (2011-03-02)

Highly hydrophilic compounds belonging to biogenic amines were analysed in the reversed-phase system, modified with the addition of ionic liquids: 1-ethyl-3-methyl-imidazolium hexafluorophosphate (EMIM PF(6)) and chaotropic salt NaPF(6) on Discovery HS C18 column at acidic conditions. The effect of the

High-throughput LC-MS/MS assay for 6-methoxy-2-naphthylacetic acid, an active metabolite of nabumetone in human plasma and its application to bioequivalence study.

Bhavin N Patel et al.

Biomedical chromatography : BMC, 22(11), 1213-1224 (2008-07-25)

A simple, precise and accurate assay for the determination of 6-methoxy-2-naphthylacetic acid (6-MNA), an active metabolite of nabumetone in human plasma, was developed and validated using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The analyte (6-MNA) and propranolol (internal standard, IS) were

Determination of lipoic acid in human plasma by HPLC-ECD using liquid-liquid and solid-phase extraction: Method development, validation and optimization of experimental parameters.

Abad Khan et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(28), 2782-2788 (2010-09-11)

A rapid, inexpensive, sensitive and specific HPLC-ECD method for the determination of lipoic acid in human plasma was developed and validated over the linearity range of 0.001-10μg/ml using naproxen sodium as an internal standard (IS). Extraction of lipoic acid and

Method development and validation for simultaneous determination of lumefantrine and its major metabolite, desbutyl lumefantrine in human plasma using RP-HPLC/UV detection.

Fazli Khuda et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 944, 114-122 (2013-12-10)

A simple, specific, precise and rapid RP-HPLC-UV method was developed for simultaneous determination of lumefantrine and its metabolite desbutyl lumefantrine in human plasma. Experimental parameters were optimized and the method was validated according to standard guidelines. The method showed adequate

查看所有相关文献

文件

Discovery^® HS C18 (5 µm) HPLC Columns